These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 6655115)

  • 1. [Action of nitrosoalkylureas and the longevity of tumor-bearing animals].
    Krutova TV; Kondradov AA; Ostrovskaia LA
    Izv Akad Nauk SSSR Biol; 1983; (6):843-50. PubMed ID: 6655115
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological activity of hydroxylated chloroethylnitrosoureas.
    Zeller WJ; Frühauf S; Chen G; Eisenbrand G; Lijinsky W
    Cancer Res; 1989 Jun; 49(12):3267-70. PubMed ID: 2720679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothetical mechanism of therapeutic synergism induced by the combination of 6-thioguanine and 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride.
    Fujimoto S; Ogawa M; Sakurai Y
    Cancer Res; 1982 Oct; 42(10):4079-85. PubMed ID: 6955008
    [No Abstract]   [Full Text] [Related]  

  • 4. New derivatives of CNC-amino acids and -oligopeptides: experimental antitumor activity.
    Zeller WJ
    J Cancer Res Clin Oncol; 1986; 111(2):154-6. PubMed ID: 3700459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumour activity of a new water-soluble nitrosoureido sugar: CY233 (NSC 609224).
    Gosse C; Atassi G; Letourneux Y; Ardouin P; Gouyette A; Fournier JP; Roger P
    Anticancer Res; 1988; 8(6):1419-22. PubMed ID: 3218975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of mutagenicity, antitumor activity, and chemical properties of selected nitrosoureas and nitrosoamides.
    Brundrett RB; Colvin M; White EH; McKee J; Hartman PE; Brown DL
    Cancer Res; 1979 Apr; 39(4):1328-33. PubMed ID: 421216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of the novel nitrosourea S10036 in rodent tumors.
    Filippeschi S; Colombo T; Bassani D; De Francesco L; Arioli P; D'Incalci M; Bartosek I; Guaitani A
    Anticancer Res; 1988; 8(6):1351-4. PubMed ID: 3064716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An improved method for analyzing survival data from combination chemotherapy experiments.
    Carter WH; Stablein DM; Wampler GL
    Cancer Res; 1979 Sep; 39(9):3446-53. PubMed ID: 476674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The oncostatic and immunosuppressive action of new nitrosourea derivatives containing sugar radicals.
    Imbach JL; Montero JL; Moruzzi A; Serrou B; Chenu E; Hayat M; Mathe G
    Biomedicine; 1975 Dec; 23(10):410-3. PubMed ID: 1222217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antitumor effect of compounds synthesized in the Division of Synthetic Chemistry (V) (author's transl)].
    Miyahara M; Kamiya S; Nakadate M; Sueyoshi S; Tanno M; Miyahara M
    Eisei Shikenjo Hokoku; 1981; 99():111-3. PubMed ID: 7332796
    [No Abstract]   [Full Text] [Related]  

  • 11. Antitumor activity of the 3'-chloroethylnitrosourea analog of thymidine and the prevention by co-administered thymidine of lethality but not of anticancer activity.
    Lin TS; Fischer PH; Marsh JC; Prusoff WH
    Cancer Res; 1982 May; 42(5):1624-9. PubMed ID: 7066884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of the kinetic parameters of tumor growth and an evaluation of the antitumor activity of chemotherapeutic preparations based on life expectancy].
    Konradov AA; Dronova LM; Erokhin VN; Belich EI; Korman DB
    Izv Akad Nauk SSSR Biol; 1982; (3):419-27. PubMed ID: 7096779
    [No Abstract]   [Full Text] [Related]  

  • 13. Biochemical aspects of drug combinations.
    Brockman RW
    Cancer Chemother Rep 2; 1974 Mar; 4(1):115-29. PubMed ID: 4135108
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. X.
    Kline I; Gang M; Tyrer DD; Venditti JM; Artis EW; Goldin A
    Cancer Chemother Rep 2; 1972 Nov; 3(1):1-69. PubMed ID: 4660732
    [No Abstract]   [Full Text] [Related]  

  • 15. [Kinetic study of the effect of N-nitroso-N-alkylurea on the development of leukemia L1210].
    Ostrovskaia LA; Sokolova IS; Gorbacheva LB
    Vopr Onkol; 1977; 23(3):59-63. PubMed ID: 898797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
    Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
    Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxicity of methylglyoxal bis(guanylhydrazone) in combination with alpha-difluoromethylornithine against HeLa cells and mouse L1210 leukemia.
    Sunkara PS; Prakash NJ; Chang CC; Sjoerdsma A
    J Natl Cancer Inst; 1983 Mar; 70(3):505-9. PubMed ID: 6403743
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A.
    Rose WC; Schurig JE; Huftalen JB; Bradner WT
    Cancer Res; 1983 Apr; 43(4):1504-10. PubMed ID: 6831399
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative study of the antitumor effectiveness of a series of nitrosoalkylureas].
    Ostrovskaia LA; Serebrianyĭ AM; Rapoport IA
    Izv Akad Nauk SSSR Biol; 1977; (2):264-72. PubMed ID: 886065
    [No Abstract]   [Full Text] [Related]  

  • 20. Attempted drug-tumor sensitivity matching using diffusion chamber-cultivated cells.
    Mason BH; Cain BF
    Cancer Treat Rep; 1978 Dec; 62(12):2035-43. PubMed ID: 751713
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.